H 
Henry Schein HSIC · USD
Health Care · Health Care Providers & Services · US listing · 🇺🇸 United States
S&P 500
88.41
+2.74%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in USD, from our data supplier.
Revenue
$13.18bn
FY2016FY2025
Net income
$398.0m
FY2016FY2025
Free cash flow
$573.0m
FY2016FY2025
Shareholders' equity
$3.25bn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $13.18bn | $12.67bn | $12.34bn | $12.65bn | $12.40bn | $10.12bn | $9.99bn | $13.20bn | $12.46bn | $11.57bn |
| Gross profit | $3.84bn | $3.77bn | $3.65bn | $3.65bn | $3.67bn | $2.81bn | $3.09bn | $2.91bn | $3.40bn | $3.23bn |
| Operating income | $758.0m | $729.0m | $714.0m | $938.0m | $854.8m | $567.4m | $733.0m | $693.5m | $864.7m | $817.5m |
| Net income | $398.0m | $390.0m | $416.0m | $538.0m | $623.9m | $402.2m | $508.0m | $535.9m | $406.3m | $506.8m |
| Diluted earnings per share | 3.36 | 3.10 | 3.18 | 3.96 | 4.45 | 2.81 | 3.45 | 3.50 | 2.62 | 3.15 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $11.21bn | $10.22bn | $10.57bn | $8.61bn | $8.48bn | $7.77bn | $7.15bn | $8.50bn | $7.86bn | $6.76bn |
| Cash and short-term investments | $156.0m | $122.0m | $171.0m | $117.0m | $118.0m | $421.2m | $106.1m | $56.9m | $174.7m | $62.4m |
| Total liabilities | $6.42bn | $5.38bn | $5.42bn | $3.94bn | $3.81bn | $3.46bn | $3.23bn | $4.65bn | $4.21bn | $3.35bn |
| Debt | $3.19bn | $2.61bn | $2.43bn | $1.15bn | $949.3m | $763.7m | $822.1m | $1.96bn | $1.67bn | $1.22bn |
| Shareholders' equity | $3.25bn | $3.39bn | $3.65bn | $3.45bn | $3.42bn | $3.35bn | $3.00bn | $2.96bn | $2.81bn | $2.79bn |
| Shares outstanding | 118m | 126m | 131m | 136m | 140m | 143m | 147m | 153m | 155m | 161m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | $712.0m | $848.0m | $500.0m | $602.0m | $709.6m | $599.0m | $654.1m | $684.7m | $545.5m | $615.5m |
| Capital spending | −$139.0m | −$187.0m | −$187.0m | −$96.0m | −$79.0m | −$49.0m | −$76.2m | −$90.6m | −$81.5m | −$70.2m |
| Free cash flow | $573.0m | $661.0m | $313.0m | $506.0m | $630.6m | $550.0m | $577.9m | $594.1m | $464.0m | $545.3m |
| Dividends paid | — | — | −$2.10bn | −$30.0m | −$7.5m | −$14.3m | −$148.1m | −$17.5m | −$29.1m | −$32.4m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.46bn | $3.37bn | $3.44bn | $3.34bn | $3.24bn | $3.17bn | $3.19bn | $3.17bn |
| Gross profit | $1.10bn | $1.07bn | $1.06bn | $1.03bn | $1.02bn | $1.00bn | $993.0m | $993.0m |
| Operating income | $200.0m | $182.0m | $188.0m | $199.0m | $175.0m | $202.0m | $193.0m | $207.0m |
| Net income | $94.0m | $107.0m | $101.0m | $101.0m | $86.0m | $110.0m | $94.0m | $99.0m |
| Diluted earnings per share | 0.82 | 0.94 | 0.85 | 0.83 | 0.70 | 0.88 | 0.75 | 0.78 |
| Cash from operations | $242.0m | −$97.0m | $381.0m | $174.0m | $120.0m | $37.0m | $204.0m | $151.0m |
| Capital spending | −$46.0m | −$39.0m | −$43.0m | −$33.0m | −$32.0m | −$43.0m | −$45.0m | −$34.0m |
| Free cash flow | $196.0m | −$136.0m | $338.0m | $141.0m | $88.0m | −$6.0m | $159.0m | $117.0m |
| Total assets | $11.38bn | $11.30bn | $11.21bn | $11.10bn | $10.91bn | $10.48bn | $10.22bn | $10.61bn |
| Cash and short-term investments | $157.0m | $138.0m | $156.0m | $136.0m | $145.0m | $127.0m | $122.0m | $126.0m |
| Debt | $3.54bn | $3.49bn | $3.07bn | $3.07bn | $2.99bn | $2.83bn | $2.48bn | $2.54bn |
| Shareholders' equity | $3.16bn | $3.27bn | $3.25bn | $3.36bn | $3.44bn | $3.31bn | $3.39bn | $3.50bn |
Financial ratios
Data as of 8 Oct 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Gross margin | 29.1% | 29.7% | 29.6% | 28.9% | 29.6% | 27.8% |
| Operating margin | 5.3% | 5.1% | 5.1% | 6.0% | 6.9% | 5.3% |
| Net margin | 3.0% | 3.1% | 3.4% | 4.3% | 5.0% | 4.0% |
| Return on equity | 12.3% | 11.5% | 11.4% | 15.6% | 18.2% | 12.0% |
| Return on assets | 3.5% | 3.8% | 3.9% | 6.3% | 7.4% | 5.2% |
| Free cash flow yield | 8.6% | 9.8% | 6.3% | 6.1% | 6.7% | 5.4% |
| Revenue growth | 4.0% | 2.7% | -2.4% | 2.0% | 22.5% | 1.3% |
| Earnings growth | 2.1% | -6.3% | -22.7% | -13.8% | 55.1% | -20.8% |
| Current ratio | 1.38x | 1.42x | 1.67x | 1.79x | 1.67x | 1.66x |
| Debt to equity | 0.98x | 0.77x | 0.67x | 0.35x | 0.28x | 0.23x |
| Equity ratio | 28.9% | 33.2% | 34.6% | 40.0% | 40.4% | 43.1% |
| Interest coverage | 4.63x | 4.92x | 7.23x | 17.39x | 31.09x | 13.08x |
| Buybacks as a share of market value | 5.8% | 3.9% | 3.8% | 3.2% | 2.1% | 2.5% |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 1.4% | 5.4% | 2.2% |
| Operating income | -6.9% | 6.0% | -0.1% |
| Net income | -9.6% | -0.2% | -1.8% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 29.4% | 29.3% | 29.2% | 28.2% |
| Operating margin | 5.8% | 6.2% | 6.2% | 6.4% |
| Net margin | 3.0% | 3.4% | 3.8% | 4.0% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | 22.5 | 22.3 | 23.8 | 20.2 | 17.4 | 23.8 | 19.3 | 22.4 | 26.7 | 24.1 |
| Price to sales | 0.7 | 0.7 | 0.8 | 0.9 | 0.9 | 0.9 | 1.0 | 0.9 | 0.9 | 1.1 |
Market value over time
30 Nov 2016 to 7 Oct 2026, in USD
$9.58bn$9.57bn
Share price return
Finished calendar years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Return | 9% | -5% | -8% | 11% | 10% | -0% | -14% | 9% | -6% | 98% |
Dividends and splits
Per share, in the currency the company pays
Paid for 0 years.
- 2-for-1 split · 15 Sept 2017
- 2-for-1 split · 1 Mar 2005
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.